Bio

Mayan Katz is a partner in Goodwin’s Life Sciences group. Mr. Katz represents private and public companies and investors in the pharmaceutical, medical device, biotechnology and digital health sectors throughout the corporate lifecycle. Mr. Katz advises both buyers and sellers on a wide range of mergers and acquisitions, including structured transactions, divestitures, spin-outs, joint ventures, and strategic alliances. He also has extensive experience counseling on startup and formation matters, venture capital financings, general corporate matters, deSPAC transactions and other strategic and complex transactions. Mr. Katz is a leader in the firm’s Israel practice and also maintains an active pro bono practice. He joined the firm in 2018.